跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PREBALIN CAPSULE 25MG - HSA Drug Approval Details
Approvals
/
HSA
/
PREBALIN CAPSULE 25MG
Approved
THERAPEUTIC
PREBALIN CAPSULE 25MG
PHARMATHEN S.A. (PRIMARY AND SECONDARY PACKAGER) - GREECEPHARMATHEN INTERNATIONAL SA (GREECE)
🇸🇬 Health Sciences Authority
Approval Date
May 15, 2020
Approval ID
4a6a2c9ab4083b1e
Company
PHARMATHEN S.A. (PRIMARY AND SECONDARY PACKAGER) - GREECEPHARMATHEN INTERNATIONAL SA (GREECE)
Type
Therapeutic
Approval Details
Approval Id
4a6a2c9ab4083b1e
Drug Name
PREBALIN CAPSULE 25MG
Product Name
PREBALIN CAPSULE 25MG
Approval Number
SIN15941P
Approval Date
2020-05-15
Registrant
SEA PHARMA CONSULTANCY PTE LTD
Licence Holder
SEA PHARMA CONSULTANCY PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
N03AX16
Atc Item Name
xn 03 ax 16
Pharma Manufacturer Name
SEA PHARMA CONSULTANCY PTE. LTD.
Company Detail Path
/organization/sea-pharma-consultancy-pte-ltd
Active Ingredients
Pregabalin
25 mg
PREGABALIN
25 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 15, 2020
Approval ID
4a6a2c9ab4083b1e
Type
Therapeutic
Back to HSA Approvals